Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data.

doi:10.1186/s12885-021-08713-8

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data.

BMC cancer - 31 Aug 2021

Gutiérrez Lourdes, Royuela Ana, Carcereny Enric, López-Castro Rafael, Rodríguez-Abreu Delvys, Massuti Bartomeu, González-Larriba José Luis, García-Campelo Rosario, Bosch-Barrera Joaquim, Guirado María, Camps Carlos, Dómine Manuel, Bernabé Reyes, Casal Joaquín, Oramas Juana, Ortega Ana Laura, Sala Mª Angeles, Padilla Airam, Aguiar David, Juan-Vidal Oscar, Blanco Remei, Del Barco Edel, Martínez-Banaclocha Natividad, Benítez Gretel, de Vega Blanca, Hernández Ainhoa, Saigi Maria, Franco Fernando, Provencio Mariano

Abstract excerpt

BACKGROUND: There is a lack of useful diagnostic tools to identify EGFR mutated NSCLC patients with long-term survival. This study develops a prognostic model using real world data to assist clinicians to predict survival beyond 24 months. METHODS: EGFR mutated stage IIIB and IV NSCLC patients diagnosed between January 2009 and December 2017 included in the Spanish Lung Cancer Group (SLCG) thoracic tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Survivors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Chemoradiotherapy

Share to ErbB Receptors

Share to Follow-Up Studies

Share to Models, Statistical

Share to Nomograms

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 34465283
DOI: 10.1186/s12885-021-08713-8
PMCID: PMC8406921

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data.PMID 34465283Read ↗

To establish a prognostic model of epidermal growth factor receptor mutated non-small cell lung cancer patients based on Least Absolute Shrinkage and Selection Operator regression.Semantic proximity Read ↗

Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIs.Semantic proximity Read ↗

Establishment of an Adjusted Prognosis Analysis Model for Initially Diagnosed Non-Small-Cell Lung Cancer With Brain Metastases From Sun Yat-Sen University Cancer Center.Semantic proximity Read ↗

Real-life management and outcomes of octogenarians with non-small-cell lung cancer: A 10-year evolution.Semantic proximity Read ↗

The Brain-Lung Immunotherapy Prognostic (BLIP) Score: A Novel Robust Tool for Prognostication in Non-Small Cell Lung Cancer Patients with Brain MetastasesSemantic proximity Read ↗

Development and Validation of a Survival Prediction Model for Lung Squamous Cell CarcinomaSemantic proximity Read ↗

Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer.Semantic proximity Read ↗

Characteristics and overall survival of patients with early-stage non-small cell lung cancer: A cohort study in Denmark.Semantic proximity Read ↗

Prognostic nomograms for hormone receptor-positive breast cancer with lung metastasis: a SEER-based studySemantic proximity Read ↗

Real-world survival outcomes to first-line chemoimmunotherapy and biomarker analysis in extensive-stage small-cell lung cancerSemantic proximity Read ↗

Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort.Semantic proximity Read ↗

Predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients through logistic regression: a model incorporating clinical characteristics, computed tomography (CT) imaging features, and tumor marker levels.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.